Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
- Author
- KOCH, Andrea1 2 3 ; BERGMAN, Bengt4 5 ; HOLMBERG, Erik6 ; SEDERHOLM, Christer3 ; EK, Lars7 ; KOSIERADZKI, Jaroslaw8 ; LAMBERG, Kristina9 ; THANING, Lars10 ; YDREBORG, Sven-Olof11 ; SÖRENSON, Sverre11 2 3
[1] Allergy Centre (Allergicentrum), University Hospital, Linköping, Sweden
[2] Department of Medical and Health Sciences, Linköping University, Sweden
[3] Department of Pulmonary Medicine, University Hospital, Linköping, Sweden
[4] Department of Respiratory Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
[5] Institution of Medicine, Gothenburg University, Sweden
[6] Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden
[7] Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund, Sweden
[8] Department of Respiratory Medicine and Allergology, Skåne University Hospital, Malmö, Sweden
[9] Department of Pulmonary Medicine, Uppsala University Hospital, Uppsala, Sweden
[10] Department of Pulmonary Medicine, Uniuersity Hospital, Orebro, Sweden
[11] Department of Medicine, County Hospital Ryhov, Jönköping, Sweden
On behalf of the Swedish Lung Cancer Study Group, Sweden - Source
European journal of cancer (1990). 2011, Vol 47, Num 10, pp 1546-1555, 10 p ; ref : 32 ref
- ISSN
- 0959-8049
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Celecoxib Chemotherapy Cyclooxygenase-2 inhibitor Non-small cell lung cancer Palliative treatment Quality of life
- Keyword (fr)
- Cancer du poumon Cancérologie Carcinome non petite cellule bronchopulmonaire Chimiothérapie Célécoxib Essai clinique phase III Essai clinique Homme Inhibiteur cyclooxygenase 2 Qualité de vie Stade avancé Survie Traitement palliatif Suède Cancer Enzyme Inhibiteur enzyme Oxidoreductases Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Prostaglandin-endoperoxide synthase Traitement Tumeur maligne Europe
- Keyword (en)
- Lung cancer Cancerology non-small cell lung carcinoma Chemotherapy Celecoxib Phase III trial Clinical trial Human Cyclooxygenase 2 inhibitor Quality of life Advanced stage Survival Palliative treatment Sweden Cancer Enzyme Enzyme inhibitor Oxidoreductases Respiratory disease Bronchus disease Lung disease Prostaglandin-endoperoxide synthase Treatment Malignant tumor Europe
- Keyword (es)
- Cáncer del pulmón Cancerología Carcinoma no pequeňa célula bronchopulmonar Quimioterapia Celecoxib Ensayo clínico fase III Ensayo clínico Hombre Inhibidor cyclooxygenase 2 Calidad vida Estadio avanzado Sobrevivencia Tratamiento paliativo Suecia Cáncer Enzima Inhibidor enzima Oxidoreductases Aparato respiratorio patología Bronquio patología Pulmón patología Prostaglandin-endoperoxide synthase Tratamiento Tumor maligno Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24293991
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ejca.2011.03.035 
https://dx.doi.org/10.1016/j.ejca.2011.03.035
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2011.03.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1546\";s:8:\"\u0000*\u0000epage\";s:4:\"1555\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KOCH\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Andrea\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:14:\"BERGMAN, Bengt\";i:1;s:14:\"HOLMBERG, Erik\";i:2;s:19:\"SEDERHOLM, Christer\";i:3;s:8:\"EK, Lars\";i:4;s:21:\"KOSIERADZKI, Jaroslaw\";i:5;s:17:\"LAMBERG, Kristina\";i:6;s:13:\"THANING, Lars\";i:7;s:19:\"YDREBORG, Sven-Olof\";i:8;s:17:\"S\u00d6RENSON, Sverre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2011.03.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1546\";s:8:\"\u0000*\u0000epage\";s:4:\"1555\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KOCH\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Andrea\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:14:\"BERGMAN, Bengt\";i:1;s:14:\"HOLMBERG, Erik\";i:2;s:19:\"SEDERHOLM, Christer\";i:3;s:8:\"EK, Lars\";i:4;s:21:\"KOSIERADZKI, Jaroslaw\";i:5;s:17:\"LAMBERG, Kristina\";i:6;s:13:\"THANING, Lars\";i:7;s:19:\"YDREBORG, Sven-Olof\";i:8;s:17:\"S\u00d6RENSON, Sverre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2011.03.035\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2011.03.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1546\";s:8:\"\u0000*\u0000epage\";s:4:\"1555\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KOCH\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Andrea\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:14:\"BERGMAN, Bengt\";i:1;s:14:\"HOLMBERG, Erik\";i:2;s:19:\"SEDERHOLM, Christer\";i:3;s:8:\"EK, Lars\";i:4;s:21:\"KOSIERADZKI, Jaroslaw\";i:5;s:17:\"LAMBERG, Kristina\";i:6;s:13:\"THANING, Lars\";i:7;s:19:\"YDREBORG, Sven-Olof\";i:8;s:17:\"S\u00d6RENSON, Sverre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2011.03.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1546\";s:8:\"\u0000*\u0000epage\";s:4:\"1555\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KOCH\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Andrea\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:14:\"BERGMAN, Bengt\";i:1;s:14:\"HOLMBERG, Erik\";i:2;s:19:\"SEDERHOLM, Christer\";i:3;s:8:\"EK, Lars\";i:4;s:21:\"KOSIERADZKI, Jaroslaw\";i:5;s:17:\"LAMBERG, Kristina\";i:6;s:13:\"THANING, Lars\";i:7;s:19:\"YDREBORG, Sven-Olof\";i:8;s:17:\"S\u00d6RENSON, Sverre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2011.03.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1546\";s:8:\"\u0000*\u0000epage\";s:4:\"1555\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KOCH\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Andrea\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:14:\"BERGMAN, Bengt\";i:1;s:14:\"HOLMBERG, Erik\";i:2;s:19:\"SEDERHOLM, Christer\";i:3;s:8:\"EK, Lars\";i:4;s:21:\"KOSIERADZKI, Jaroslaw\";i:5;s:17:\"LAMBERG, Kristina\";i:6;s:13:\"THANING, Lars\";i:7;s:19:\"YDREBORG, Sven-Olof\";i:8;s:17:\"S\u00d6RENSON, Sverre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:190:\"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
